Pharmafile Logo

dual tasking

Personalized Digital Health Coaching

Eugene Borukhovich, Chairman & COO of YourCoach.Health, discusses his transition from Global Head of Digital Health at Bayer to full-time entrepreneur. We also talk about YourCoach’s mission, the impact of COVID-19...

Impetus Digital

Empowering Medtech Innovation

Scott Phillips, President at StarFish Medical, shares his ongoing work to empower MedTech innovation in Canada and overseas. We also discuss how COVID-19 has impacted the MedTech industry and the many...

Impetus Digital

- PMLiVE

BioNTech bolsters COVID-19 vaccine capacity with Novartis deal

Deal will expand production capacity for BNT162b2 candidate

- PMLiVE

Moderna inks R&D agreements with Vertex and Chiesi

Biotech agrees to separate deals for the development of gene-editing and mRNA therapies

- PMLiVE

The Lucid Group Wellbeing Champions embark on their MHFA training

A mentally sound organisation is good for talent and business. Statistics from Mental Health First Aid (MHFA) England point out to mental health illness (such as depression or anxiety) accounting...

Lucid Group Communications Limited

- PMLiVE

Gilead agrees $21bn buyout of Immunomedics

Pharma company gains rights to ADC Trodelvy

- PMLiVE

Shionogi’s Gram-negative antibiotic launches in the UK

Novel antibiotic is indicated for use against Gram-negative bacterial infections

- PMLiVE

Lilly’s Olumiant combined with Gilead’s remdesivir hits the mark in COVID-19

The combination treatment hit the primary study endpoint of a reduction in recovery time

- PMLiVE

Route 66: can remote working put two-thirds of us back on the road to engaged employment?

Pre-pandemic, 66% of the world’s workforce weren’t engaged in their jobs – Chris Ross examines how the rush to remote working has impacted employee engagement

- PMLiVE

Leadership change within Bedrock Group

Marie Little appointed Managing Director of Bedrock Healthcare Communications Limited

Bedrock Healthcare Communications

- PMLiVE

Sanofi, GSK to launch human trials of COVID-19 vaccine

Vaccine combines Sanofi’s baculovirus expression system and GSK’s AS03 adjuvant

- PMLiVE

Roche’s Ocrevus boasts positive long-term data in MS

After two years of treatment 75% of patients had no evidence of disease activity

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links